Ondansetron Tablet, Orally Disintegrating
Product Images NDC 42291-458

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 42291-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (457 30)

30 (457 30)
This text appears to be a product code for Ondansetron Orally Disintegrating Tablets, USP. These tablets are commonly used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, or surgery.*
FDA Label Image

30 (458 30)

FDA Label Image

Structure-base (Structure Base)

FDA Label Image

Structure-hcl (Structure HCl)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.